Patients With Psoriasis Treated With Brodalumab: A Pooled Post Hoc Analysis of a Marker of Liver Inflammation in Individuals With Potential Indicators of Early Nonalcoholic Fatty Liver Disease

Main Article Content

Ronald Prussick
Mark Lebwohl
Nadege Gunn
Susan Harris
Jason Vittitow
Abby Jacobson
Robert J Israel


psoriasis, brodalumab


Abstract not available.


1. Chalasani N, Younossi Z, Lavine JE, et al. Hepatology. 2018;67(1):328-357.

2. Lonardo A, Ballestri S, Marchesini G, Angulo P, Loria P. Dig Liver Dis. 2015;47(3):181-190.

3. Candia R, Ruiz A, Torres-Robles R, et al. J Eur Acad Dermatol Venereol. 2015;29(4):656-662.

4. van der Voort EA, Koehler EM, Dowlatshahi EA, et al. J Am Acad Dermatol. 2014;70(3):517-524.

5. Roberts KK, Cochet AE, Lamb PB, et al. Aliment Pharmacol Ther. 2015;41(3):293-300.

6. Miele L, Vallone S, Cefalo C, et al. J Hepatol. 2009;51(4):778-786.

7. Prussick RB, Miele L. Br J Dermatol. 2018;179(1):16-29.

8. Ganzetti G, Campanati A, Offidani A. World J Hepatol. 2015;7(3):315-326.

9. Siliq™ (brodalumab) injection, for subcutaneous use [package insert]. Bridgewater, NJ: Valeant Pharmaceuticals; 2017.

10. Hadizadeh F, Faghihimani E, Adibi P. World J Gastrointest Pathophysiol. 2017;8(2):11-26.

11. Papp KA, Leonardi C, Menter A, et al. N Engl J Med. 2012;366(13):1181-1189.

12. Papp K, Menter A, Strober B, et al. J Am Acad Dermatol. 2015;72(3):436-439.e1.

13. Lebwohl M, Strober B, Menter A, et al. N Engl J Med. 2015;373(14):1318-1328.

14. Stelara® (ustekinumab) injection, for subcutaneous or intravenous use [package insert]. Horsham, PA: Janssen Biotech, Inc.; 2018.

15. Sorbi D, Boynton J, Lindor KD. Am J Gastroenterol. 1999;94(4):1018-1022. 16. Alkhouri N, McCullough AJ. Gastroenterol Hepatol (N Y). 2012;8(10):661-668.

Most read articles by the same author(s)

1 2 3 4 5 6 7 8 9 10 > >>